TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes
Open Access
- 28 February 2013
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 131 (2), 468-476
- https://doi.org/10.1016/j.jaci.2012.10.029
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndromeJournal of Allergy and Clinical Immunology, 2011
- Genome-wide association identifies diverse causes of common variable immunodeficiencyJournal of Allergy and Clinical Immunology, 2011
- The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiencyJournal of Allergy and Clinical Immunology, 2010
- The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88Nature Immunology, 2010
- CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiencyJCI Insight, 2010
- CD20 deficiency in humans results in impaired T cell–independent antibody responsesJCI Insight, 2010
- B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humansProceedings of the National Academy of Sciences of the United States of America, 2009
- Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotesJournal of Allergy and Clinical Immunology, 2007
- Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)JCI Insight, 2007
- Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiencyNature Genetics, 2007